U.S. Healthcare Strong Balance Sheet Stocks

Clover Health Investments

Market Cap: US$1.7b

Provides medicare advantage plans in the United States.

Orthofix Medical

Market Cap: US$584.5m

Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.

IRIDEX

Market Cap: US$20.2m

An ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.

Pediatrix Medical Group

Market Cap: US$1.4b

Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

Shoulder Innovations

Market Cap: US$262.4m

Designs, develops, manufactures, and distributes implant replacement systems for shoulder arthroplasty in the United States.

Orchestra BioMed Holdings

Market Cap: US$130.6m

Operates as a biomedical company in the United States.

Artivion

Market Cap: US$1.9b

Manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Cerus

Market Cap: US$289.5m

Operates as a biomedical products company.

Syra Health

Market Cap: US$1.7m

A healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States.

UFP Technologies

Market Cap: US$1.5b

Designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.

Lucid Diagnostics

Market Cap: US$135.9m

Operates as a commercial-stage medical diagnostics technology company in the United States.

Ardent Health

Market Cap: US$1.9b

Owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States.

Vivani Medical

Market Cap: US$87.1m

A clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases.

Accuray

Market Cap: US$199.4m

Engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

KORU Medical Systems

Market Cap: US$182.6m

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

GlucoTrack

Market Cap: US$5.2m

A medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States.

NeurAxis

Market Cap: US$26.6m

A medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.

iSpecimen

Market Cap: US$7.9m

Operates marketplace that provides biospecimens to life science researchers worldwide.

RxSight

Market Cap: US$375.6m

A commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.

NeuroPace

Market Cap: US$338.1m

Operates as a medical device company in the United States.

Outset Medical

Market Cap: US$262.8m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

InfuSystem Holdings

Market Cap: US$209.4m

Through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

Axogen

Market Cap: US$800.2m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

EDAP TMS

Market Cap: US$93.5m

Develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.

Molina Healthcare

Market Cap: US$10.3b

Provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.

TransMedics Group

Market Cap: US$4.0b

A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

LifeMD

Market Cap: US$303.5m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

Biomerica

Market Cap: US$8.2m

A biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide.

Sonendo

Market Cap: US$1.2m

A commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada.

Hyperfine

Market Cap: US$119.4m

A health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.

Medical Care Technologies

Market Cap: US$502.4k

Operates in the collectibles and memorabilia industry.

Daxor

Market Cap: US$58.5m

A medical device company, provides blood volume measurement technology focused on blood volume testing.

Tandem Diabetes Care

Market Cap: US$854.1m

Designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.

Vicarious Surgical

Market Cap: US$35.4m

Develops and sells single-port surgical robot in the United States.

OPKO Health

Market Cap: US$1.2b

A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

HeartSciences

Market Cap: US$9.8m

A medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.